Streetbeat News

Products Services

AMZN

GOOG

NFLX

Amazon's introduction of an ad-supported version of Prime Video has disrupted the streaming ad market, impacting Netflix, YouTube, and TV networks. This move has led to a decrease in ad prices and forced Netflix to reduce its ad rates and introduce new offerings. Amazon's ad-supported Prime Video tier has a significant reach, and its entry into the connected TV market is beginning to show its impact.

Portfolio Pulse from Benzinga Neuro

June 14, 2024 | 11:32 am

IRON

Disc Medicine will present updated data from the AURORA and BEACON studies, as well as Phase 1b DISC-0974 and Phase 1 DISC-3405 data, at the European Hematology Association 2024 Congress.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 11:32 am

APD

ESI

Two materials sector stocks, Element Solutions Inc (NYSE:ESI) and Air Products and Chemicals Inc (NYSE:APD), are currently overbought according to their RSI values. ESI has increased its guidance for Q2 and FY24, while APD has signed a significant green hydrogen supply agreement with TotalEnergies SE (NYSE:TTE). Both stocks have seen significant recent gains.

Portfolio Pulse from Avi Kapoor

June 14, 2024 | 11:31 am

VXRT

Vaxart shares are trading higher after the company received a BARDA-funded Project NextGen award valued up to $453 million to conduct a Phase 2b study evaluating its COVID-19 oral pill vaccine candidate.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 11:24 am

NTZ

Natuzzi has been selected to furnish the meeting rooms for bilateral leader meetings at the G7 summit in Apulia.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 11:23 am

KYMR

Kymera Therapeutics has shared new clinical data from its ongoing KT-333 Phase 1 trial. The data were presented at the European Hematology Association (EHA) Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 11:21 am

IVVD

Invivyd's investigational monoclonal antibody VYD222 shows continued in vitro neutralization activity against emerging SARS-CoV-2 variants, including KP.1.1 FLiRT and KP.3. The CDC predicts KP.3 will become the dominant variant soon.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 11:17 am

AUTL

Autolus Therapeutics announced that it will present three abstracts at the upcoming European Hematology Association (EHA) Congress.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 11:14 am

BPTH

Bio-Path Holdings presented interim results from its Phase 2 study of prexigebersen in combination with decitabine and venetoclax for treating acute myeloid leukemia at the 2024 European Hematology Association Congress. The data showed that prexigebersen is well-tolerated and has demonstrated compelling efficacy in both newly diagnosed and refractory/relapsed AML patients.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 11:11 am

SNDX

Syndax Pharmaceuticals has disclosed updated data from multiple combination trials of revumenib, a potent small molecule Menin inhibitor, in patients with acute leukemias. The data shows promising results, with a 96% CRc observed in the BEAT AML trial and a 52% CRc in the AUGMENT-102 trial.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 11:09 am